Quick Takeaways
- Avoro Capital Advisors LLC filed SCHEDULE 13G for SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share (SLNO).
- Disclosed ownership: 5.4%.
- Date of event: 31 Dec 2025.
Avoro Capital Advisors LLC - 31 Dec 2025 SCHEDULE 13G Report for SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share (SLNO)
- Filing Manager
- Avoro Capital Advisors LLC
- Reporting Manager
- Avoro Capital Advisors LLC
- Symbol
- SLNO
- Shares outstanding
- 53,703,704 shares
- Disclosed Ownership
- 2,900,000 shares
- Ownership
- 5.4%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Feb 2026, 09:01:41 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Avoro Capital Advisors LLC disclosed 5.4% ownership in SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share (SLNO) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 14 Aug 2025.
- Current filing was accepted on 17 Feb 2026, 09:01.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Avoro Capital Advisors LLC | 5.4% | 2,900,000 | 2,900,000 | 0 | /s/ Scott Epstein | Scott Epstein, Chief Operating Officer and Chief Compliance Officer | |
| Behzad Aghazadeh | 5.4% | 2,900,000 | 2,900,000 | 0 | /s/ Behzad Aghazadeh | Behzad Aghazadeh, Individually |